- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 90Y-epratuzumab tetraxetan
Total 1142 results
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
Genentech, Inc.Completed
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Poland, Spain, Belgium, India, Ukraine, Brazil, United Kingdom, Hungary, Lithuania, Hong Kong
-
Genentech, Inc.Completed
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Australia, Belgium, Brazil, Bulgaria, Czechia, Estonia, France, Germany, India, Israel, Italy, Korea, Republic of, Lithuania, Mexico, Puerto Rico, Romania, Russian Federation, Spain, Taiwan, United Kingdom
-
UCB PharmaTerminatedSystemic Lupus ErythematosusUnited States, France, United Kingdom, Spain, Belgium, Netherlands, Canada, Brazil, Germany, Czech Republic, Italy
-
BiocadRecruitingBreast CancerRussian Federation
-
Ontario Clinical Oncology Group (OCOG)Terminated
-
David BushnellNational Cancer Institute (NCI); National Institutes of Health (NIH); Holden...Active, not recruitingNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting | Neuroendocrine Tumor, MalignantUnited States
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
UCB PharmaCompleted
-
BiocadActive, not recruiting
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
The Christie NHS Foundation TrustRecruiting
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)RecruitingHER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of BreastUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States
-
Spectrum Pharmaceuticals, IncTerminated
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Roche Pharma AGCompletedEsophageal CarcinomaNetherlands
-
SCRI Development Innovations, LLCSirtex MedicalCompleted
-
Fudan UniversityCompleted
-
Nexpep Pty LtdCompleted
-
IpsenTerminatedSmall Cell Lung Cancer and Breast CancerUnited States, Austria, France, Switzerland, Germany, United Kingdom, Belgium
-
Hospices Civils de LyonNot yet recruiting
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Institut fuer anwendungsorientierte Forschung und...CompletedPrimary Non-Hodgkin-Lymphoma | Refractory Non-Hodgkin-Lymphoma | CD20+ Aggressive Non-Hodgkin's LymphomaGermany
-
Institut für Klinische Krebsforschung IKF GmbH...Trium Analysis Online GmbHCompletedStomach Cancer | Gastroesophageal Junction CancerGermany
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Genentech, Inc.Approved for marketing
-
Centre Leon BerardOncoTherapy Science, Inc.Terminated
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedBreast Cancer Metastases | HER2 Positive BreastUnited States
-
UCB PharmaCompletedSystemic Lupus ErythematosusUnited States, Brazil, Canada, France, Germany, Hungary, India, Italy, Mexico, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom
-
BiogenTerminatedColorectal Cancer | MetastasesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteWithdrawnBreast CancerUnited States
-
TakedaCompletedJapanese Healthy Adult Male ParticipantsJapan
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
Novartis PharmaceuticalsRecruitingProstatic NeoplasmKorea, Republic of, Singapore, United States, Canada, Poland, Spain, Czechia
-
Masonic Cancer Center, University of MinnesotaTerminated
-
BeBetter Med IncActive, not recruitingRelapsed or Refractory Diffuse Large B-cell LymphomaChina
-
Gilead SciencesCompleted
-
Vadim S KoshkinEli Lilly and Company; Prostate Cancer FoundationActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Castration-resistant Prostate Cancer | Metastatic Prostate Adenocarcinoma | Metastatic Castration-resistant Prostate CarcinomaUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
AbbVieTerminatedHealthy VolunteersUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-PositiveRecurrent or Metastatic Breast Cancer
-
Massachusetts General HospitalDana-Farber Cancer Institute; TakedaNot yet recruiting
-
Haag-Streit AGAravind Eye Hospitals, IndiaNot yet recruiting
-
Hoffmann-La RocheCompleted
-
Molecular Insight Pharmaceuticals, Inc.Withdrawn
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedRecurrent Disease | DLBCL | MCLItaly
-
Gruppo Italiano Multiregionale per lo studio dei...Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteTerminated